Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
319.25x
As of Sep 29, 2025
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Sep 29, 2025 | 319.25x |
| Sep 26, 2025 | 311.95x |
| Sep 25, 2025 | 296.54x |
| Sep 24, 2025 | 299.78x |
| Sep 23, 2025 | 289.24x |
| Sep 22, 2025 | 294.11x |
| Sep 19, 2025 | 287.62x |
| Sep 18, 2025 | 283.56x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison